UBS AM
STAA icon

UBS AM’s STAAR Surgical STAA Stock Holding History

UBS AM’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
107,417
+9,836
+10% +$273K ﹤0.01% 1868
2026
Q1 		$1.82M Buy
97,581
+55
+0.1% +$1.05K ﹤0.01% 2080
2025
Q4 		$2.25M Sell
97,526
-30,875
-24% -$796K ﹤0.01% 1842
2025
Q3 		$3.45M Sell
128,401
-90,778
-41% -$2.16M ﹤0.01% 1540
2025
Q2 		$3.68M Buy
219,179
+95,832
+78% +$1.69M ﹤0.01% 1849
2025
Q1 		$2.17M Buy
123,347
+12,841
+12% +$258K ﹤0.01% 1959
2024
Q4 		$2.68M Buy
110,506
+13,075
+13% +$373K ﹤0.01% 1897
2024
Q3 		$3.62M Sell
97,431
-2,617
-3% -$97.6K ﹤0.01% 1737
2024
Q2 		$4.76M Buy
100,048
+40,867
+69% +$1.79M ﹤0.01% 1519
2024
Q1 		$2.27M Buy
59,181
+7,057
+14% +$229K ﹤0.01% 1636
2023
Q4 		$1.63M Buy
52,124
+1
+0% +$36 ﹤0.01% 1784
2023
Q3 		$2.09M Sell
52,123
-157,612
-75% -$7.38M ﹤0.01% 1602
2023
Q2 		$13.4M Hold
209,735
– – 0.01% 864
2023
Q1 		$13.4M Buy
209,735
+1,429
+0.7% +$93.3K 0.01% 864
2022
Q4 		$10.1M Buy
208,306
+12,429
+6% +$780K 0.01% 931
2022
Q3 		$13.8M Sell
195,877
-33,804
-15% -$2.89M 0.01% 860
2022
Q2 		$16.3M Buy
229,681
+751
+0.3% +$48.4K 0.01% 790
2022
Q1 		$18.3M Buy
228,930
+43,091
+23% +$3.21M 0.01% 864
2021
Q4 		$17M Sell
185,839
-78,545
-30% -$8.43M 0.01% 945
2021
Q3 		$34M Sell
264,384
-4,107
-2% -$575K 0.01% 731
2021
Q2 		$40.9M Sell
268,491
-15,753
-6% -$2.07M 0.02% 682
2021
Q1 		$30M Sell
284,244
-7,564
-3% -$757K 0.01% 757
2020
Q4 		$23.1M Sell
291,808
-50,322
-15% -$3.68M 0.01% 813
2020
Q3 		$19.4M Buy
342,130
+2,174
+0.6% +$117K 0.01% 773
2020
Q2 		$20.9M Buy
339,956
+18,452
+6% +$754K 0.01% 723
2020
Q1 		$10.4M Sell
321,504
-50,539
-14% -$1.7M 0.01% 852
2019
Q4 		$13.1M Buy
372,043
+346,370
+1,349% +$11.4M 0.01% 871
2019
Q3 		$662K Buy
25,673
+6,449
+34% +$196K ﹤0.01% 2151
2019
Q2 		$565K Buy
19,224
+7,205
+60% +$208K ﹤0.01% 2157
2019
Q1 		$411K Buy
12,019
+2,319
+24% +$82K ﹤0.01% 2187
2018
Q4 		$310K Sell
9,700
-5,167
-35% -$201K ﹤0.01% 2207
2018
Q3 		$714K Buy
14,867
+5,767
+63% +$236K ﹤0.01% 1938
2018
Q2 		$282K Buy
+9,100
New +$213K ﹤0.01% 2328
2016
Q4 		– Sell
-28,400
Closed -$267K – 2645
2016
Q3 		$267K Hold
28,400
– – ﹤0.01% 2325
2016
Q2 		$156K Hold
28,400
– – ﹤0.01% 2516
2016
Q1 		$210K Hold
28,400
– – ﹤0.01% 2415
2015
Q4 		$203K Buy
28,400
+300
+1% +$2.43K ﹤0.01% 2529
2015
Q3 		$218K Hold
28,100
– – ﹤0.01% 2445
2015
Q2 		$271K Buy
28,100
+5,800
+26% +$53.8K ﹤0.01% 2424
2015
Q1 		$166K Buy
22,300
+9,400
+73% +$68.7K ﹤0.01% 2522
2014
Q4 		$118K Hold
12,900
– – ﹤0.01% 2555
2014
Q3 		$137K Hold
12,900
– – ﹤0.01% 2457
2014
Q2 		$217K Hold
12,900
– – ﹤0.01% 2371
2014
Q1 		$243K Hold
12,900
– – ﹤0.01% 2319
2013
Q4 		$209K Hold
12,900
– – ﹤0.01% 2352
2013
Q3 		$175K Buy
+12,900
New +$152K ﹤0.01% 2370

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS AM's STAA Position: Q2 2026 in Review

UBS AM increased its STAAR Surgical (STAA) stake by 10% in Q2 2026, buying an estimated $273K and bringing the position to 107,417 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

UBS AM first reported a position in STAA in Q3 2013 and has held it in 46 quarters since. The position peaked at $40.9M in Q2 2021. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • UBS AM held 107,417 shares of STAAR Surgical worth $3.08M as of Q2 2026.
  • UBS AM bought 9,836 STAAR Surgical shares in Q2 2026, an estimated $273K.
  • STAAR Surgical made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1868 holding.
  • UBS AM first reported a position in STAAR Surgical in Q3 2013 and has held it in 46 quarters since.
  • UBS AM's STAAR Surgical position peaked at $40.9M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.